NEW YORK (GenomeWeb) – Microbiology and life science company Hygiena announced today that it will acquire DuPont's global food safety diagnostics business.
The acquisition includes all of DuPont Diagnostics' business assets, including the BAX foodborne pathogens and spoilage organisms testing platform; the RiboPrinter contaminating organism differentiation and identification system; BAX- and RiboPrinter-associated test kits; a sales, R&D, and manufacturing organization; and in-house production capacity.
Financial terms of the agreement were not disclosed. The transaction is expected to close in the first quarter of 2017.
"The combined company's microbiology products will cover the full manufacturing process, from in-process environment tests to finished products tests," Hygiena CEO Steve Nason said in a statement. "In addition, the combination increases our customer service presence in the United States and internationally, which will allow us to further enhance our research and development efforts and support to our combined customer base."
Hygiena serves industrial food processors, healthcare institutions, life science researchers, and other industries. The company manufactures and sells a broad range of rapid hygiene monitoring systems, environmental collection systems, and rapid dilution devices, including an adenosine triphosphate testing system. Its products are distributed in over 80 countries worldwide. The company received an investment from private equity firm Warburg Pincus earlier this year.